EU | EMA Guidance – Harnessing AI in Medicines Regulation: Use of Large Language Models (LLMs) GalleryEU | EMA Guidance – Harnessing AI in Medicines Regulation: Use of Large Language Models (LLMs)
2024, AI, EMA, Members-Only, Minor Update, RWD to Support Reg Decisions, Secondary Use of Existing Data-
USA | Draft FDA Guidance – Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice GalleryUSA | Draft FDA Guidance – Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
2024, Members-Only, Minor Update, RWD to Support Reg Decisions, Secondary Use of Existing Data, September 2024, USA-
